Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: jayhawk969 who wrote (1654)	9/16/2000 2:16:55 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 52153

J.D.: >> Two candidates that are on my list are GZTC and SEPR << Yeah, that's the sort of stuff that I was thinking of as well, although I think that it's too late to pick SEPR (not as an investment with remaining legs, but as "disruptive".... others can practice similar art, and the concept has been around for some time now). Playing this game, I own a tad of EPIcyte (antibody production in plants) and of a "good for what ails you" anti-oxidant company. One to look at.... INCR..... why take drugs, when you can just replace the worn out parts? Stop drinking? Why, when you can just drop into the local Jiffy Liver, and get a replacement? They also have an anti-oxidant program, and interest may spill over into "aging". Disclaimer.... I know very little about INCR. Peter.... re. ONXX. There's a good rule.... the harder a biotech "partys", the better the chance of success. A small chunk of ONXX looked like they were rehearsing diligently -- for success -- last night, at Pyramid Brewery in Berkeley.